相似文献
1
Antiplatelet therapy for carotid artery stenting.
Interv Neurol. 2013 Sep;1(3-4):151-63. doi: 10.1159/000351686.
2
Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting.
J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1374-84. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.018. Epub 2014 Feb 15.
3
Results of carotid artery stenting with distal embolic protection with improved systems: Protected Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy (PROTECT) trial.
J Vasc Surg. 2012 Apr;55(4):968-976.e5. doi: 10.1016/j.jvs.2011.10.120. Epub 2012 Jan 9.
4
Periprocedural P2Y inhibitors improve perioperative outcomes after carotid stenting by primarily decreasing strokes.
J Vasc Surg. 2023 Mar;77(3):795-803. doi: 10.1016/j.jvs.2022.10.038. Epub 2022 Oct 31.
5
Meta-analysis of redo stenting versus endarterectomy for in-stent stenosis after carotid artery stenting.
J Vasc Surg. 2021 Apr;73(4):1282-1289. doi: 10.1016/j.jvs.2020.07.102. Epub 2020 Aug 28.
6
Carotid artery stenting: Current state of evidence and future directions.
Acta Neurol Scand. 2019 Apr;139(4):318-333. doi: 10.1111/ane.13062. Epub 2019 Feb 6.
7
Postoperative ischemic events in patients undergoing carotid artery stenting using algorithmic selection for embolic protection.
Neuroradiol J. 2019 Aug;32(4):294-302. doi: 10.1177/1971400919839644. Epub 2019 Apr 11.
8
The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention.
Stroke. 2006 Jun;37(6):1572-7. doi: 10.1161/01.STR.0000221298.43117.be. Epub 2006 Apr 20.
9
Elective carotid stenting after urgent best medical treatment suppresses recurrent stroke in patients with symptomatic carotid artery severe stenosis.
Clin Neurol Neurosurg. 2020 Aug;195:105855. doi: 10.1016/j.clineuro.2020.105855. Epub 2020 May 12.
10
Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting.
J Vasc Surg. 2002 Dec;36(6):1175-85. doi: 10.1067/mva.2002.129488.
引用本文的文献
1
Antithrombotic Therapy in Carotid Artery and Intracranial Artery Stent.
J Neuroendovasc Ther. 2025;19(1). doi: 10.5797/jnet.ra.2024-0014. Epub 2024 Apr 16.
2
Intravenous thrombolysis plus mechanical thrombectomy versus mechanical thrombectomy alone for acute ischemic stroke: A systematic review and updated meta-analysis of clinical trials.
Interv Neuroradiol. 2024 Aug;30(4):550-563. doi: 10.1177/15910199221140276. Epub 2022 Nov 28.
3
Acute ischemic stroke with cervical internal carotid artery steno-occlusive lesion: multicenter analysis of endovascular approaches.
BMC Neurol. 2021 Sep 17;21(1):362. doi: 10.1186/s12883-021-02393-4.
4
Comparing Endovascular Treatment Methods in Acute Ischemic Stroke Due to Tandem Occlusion Focusing on Clinical Aspects.
Life (Basel). 2021 May 20;11(5):458. doi: 10.3390/life11050458.
5
Association of Mortality with Antiplatelet Treatment in Patients with Stent Placement or Angioplasty: A Population-Based Nested Case-Control Study.
Yonsei Med J. 2021 Jan;62(1):75-85. doi: 10.3349/ymj.2021.62.1.75.
6
Antiplatelet therapy within 24 hours of tPA: lessons learned from patients requiring combined thrombectomy and stenting for acute ischemic stroke.
J Cerebrovasc Endovasc Neurosurg. 2020 Mar;22(1):1-7. doi: 10.7461/jcen.2020.22.1.1. Epub 2020 Mar 31.
7
[Tandem occlusions in acute ischemic stroke].
Radiologe. 2019 Jul;59(7):616-621. doi: 10.1007/s00117-019-0547-0.
8
Optimal platelet function test for in-stent tissue protrusion following carotid artery stenting.
J Int Med Res. 2018 May;46(5):1866-1875. doi: 10.1177/0300060518762949. Epub 2018 Mar 19.
9
Does Antiplatelet Therapy during Bridging Thrombolysis Increase Rates of Intracerebral Hemorrhage in Stroke Patients?
PLoS One. 2017 Jan 17;12(1):e0170045. doi: 10.1371/journal.pone.0170045. eCollection 2017.
10
Diabetes mellitus and carotid artery plaques exhibiting high-intensity signals on MR angiography are related to increased platelet reactivity after carotid artery stenting.
J Neurointerv Surg. 2017 Jan;9(1):106-110. doi: 10.1136/neurintsurg-2016-012419. Epub 2016 Jul 1.
本文引用的文献
1
Selection of carotid artery stenting or endarterectomy based on magnetic resonance plaque imaging reduced periprocedural adverse events.
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1082-7. doi: 10.1016/j.jstrokecerebrovasdis.2012.07.018. Epub 2012 Aug 29.
2
Effect of cilostazol in preventing restenosis after carotid artery stenting using the carotid wallstent: a multicenter retrospective study.
AJNR Am J Neuroradiol. 2012 Dec;33(11):2167-70. doi: 10.3174/ajnr.A3127. Epub 2012 May 17.
3
Association between plaque echogenicity and embolic material captured in filter during protected carotid angioplasty and stenting.
Eur J Vasc Endovasc Surg. 2012 Jun;43(6):627-31. doi: 10.1016/j.ejvs.2012.03.004. Epub 2012 Apr 8.
4
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.
Am Heart J. 2012 Feb;163(2):182-90.e4. doi: 10.1016/j.ahj.2011.11.001.
5
High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting.
Stroke. 2011 Nov;42(11):3132-7. doi: 10.1161/STROKEAHA.111.615708. Epub 2011 Aug 25.
6
Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
Cerebrovasc Dis. 2011;32(1):65-71. doi: 10.1159/000327036. Epub 2011 May 25.
7
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
J Am Coll Cardiol. 2011 Mar 15;57(11):1264-70. doi: 10.1016/j.jacc.2010.10.035.
8
Embolic complications after carotid artery stenting or carotid endarterectomy are associated with tissue characteristics of carotid plaques evaluated by magnetic resonance imaging.
Atherosclerosis. 2011 Apr;215(2):399-404. doi: 10.1016/j.atherosclerosis.2011.01.002. Epub 2011 Jan 19.
9
Aspirin resistance: effect of clinical, biochemical and genetic factors.
Pharmacol Ther. 2011 May;130(2):213-25. doi: 10.1016/j.pharmthera.2011.01.011. Epub 2011 Feb 2.
10
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy.
BMC Med. 2011 Jan 12;9:3. doi: 10.1186/1741-7015-9-3.
Zotero 插件